Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa

被引：0
|
作者：
Oskardmay, Ashley N. [1 ]
Miles, J. Alex [1 ]
Sayed, Christopher J. [2 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
10030
引用
收藏
页码：AB45 / AB45
页数：1
相关论文
共 50 条
  • [41] Infliximab for hidradenitis suppurativa: report of seven consecutive patients
    Dupuy, A
    Fardet, L
    Kerob, D
    Levy, A
    Bachelez, H
    Morel, P
    Lebbe, C
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (06) : 482 - 482
  • [42] The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered
    Egeberg, Alexander
    Thyssen, Jacob P.
    LANCET, 2023, 401 (10378): : 708 - 710
  • [43] Hidradenitis suppurativa in Crohn's disease responding to infliximab
    Stipho, S
    Welch, R
    Feller, E
    Shah, SA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S163 - S163
  • [44] Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum Treated With Infliximab
    Groleau, Patricia F.
    Grossberg, Anna L.
    Gaspari, Anthony A.
    CUTIS, 2015, 95 (06): : 337 - 342
  • [45] Variable response of hidradenitis suppurativa to infliximab in four patients
    Usmani, N.
    Clayton, T. H.
    Everett, S.
    Goodfield, M. D. J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 204 - 205
  • [46] Serum infliximab levels and clinical response in hidradenitis suppurativa
    Benassaia, Erwin
    Bouaziz, Jean-David
    Jachiet, Marie
    Cordoliani, Florence
    Saussine, Anne
    Lepelletier, Clemence
    Goldwirt, Lauriane
    Cassius, Charles
    de Masson, Adele
    Bagot, Martine
    Bachelez, Herve
    Assan, Florence
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 306 - 312
  • [47] Efficacy of infliximab in hidradenitis suppurativa: A meta-analysis
    Shih, T.
    Lee, K.
    Grogan, T.
    De, D. R.
    Shi, V. Y.
    Hsiao, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S53 - S53
  • [48] Long-term infliximab for severe hidradenitis suppurativa
    Thielen, A. -M.
    Barde, C.
    Saurat, J. -H.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (05) : 1105 - 1107
  • [49] Adalimumab dose deintensification in hidradenitis suppurativa
    Cembrero Saralegui, Hirune
    Alfageme Roldan, Fernando
    Turrion Merino, Lucia
    Cabeza Martinez, Rita
    Elosua Gonzalez, Marta
    Roustan Gullon, Gaston
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 44 - 44
  • [50] New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab
    Acquacalda, Emilie
    Roux, Christian Hubert
    Albert, Christine
    Breuil, Veronique
    Passeron, Thierry
    Euller-Ziegler, Liana
    JOINT BONE SPINE, 2015, 82 (05) : 362 - 364
12345